IP Library Granted Patent US 8,980,893
Granted Patent B2
US 8,980,893 · App. 14/086,712 · Granted Mar 17, 2015

Antiparisitic dihydroazole compounds and compositions comprising same

Inventors: Loic Patrick Le Hir de Fallois (Atlanta, GA); Hyoung Ik Lee (Cary, NC); Douglas Edward Wilkinson (Wake Forest, NC); Brent Christopher Beck (Apex, GA)
Assignee: Merial, Inc.
C07D471/04A01N43/90A61K31/365A61K31/495A01N43/80A61K31/437A61K38/05A61K45/06C07K5/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,980,893
App. No.
14/086,712
Granted
Mar 17, 2015
Kind
B2
Abstract

The present invention relates to novel dihydroazole of formula (I) and salts thereof: Wherein R 1 , A 1 , A 2 , G, X and Y are as defined in the description, compositions thereof, processes for their preparation and their uses to prevent or treat parasitic infections or infestations in animals and as pesticides.

Claims (277)

1. A dihydroazole compound of formula (I), or a pharmaceutically or agriculturally acceptable salt thereof:

wherein:

R 1 is halogen, —CN, or alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, cycloalkyl, halocycloalkyl, alkylcycloalkyl or cycloalkylalkyl, each which is unsubstituted or substituted with one or more of halogen, hydroxy, amino, alkyl- or di(alkyl)amino, alkyl, cycloalkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, R 7 S(O)—, R 7 S(O) 2 —, R 7 C(O)—, R 7 R 8 NC(O)—, R 7 OC(O)—, R 7 C(O)O—, R 7 C(O)NR 8 —, —CN or —NO 2 ;

X is aryl or heteroaryl, which may be unsubstituted or substituted by one or more of halogen, hydroxy, amino, alkyl- or di(alkyl)amino, alkyl, cycloalkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, R 7 S(O)—, R 7 S(O) 2 —, R 7 C(O)—, R 7 R 8 NC(O)—, R 7 OC(O)—, R 7 C(O)O—, R 7 C(O)NR 8 —, —CN or —NO 2 ;

A 1 is oxygen;

A 2 is oxygen, NR 2 or CR 7 R 8 ;

G is G-1;

B 1 , B 2 , B 3 , B 4 and B 5 are independently N or C—R 9 ;

Y is hydrogen, halogen, —CN; or Y is alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, aryl, or heterocyclyl or heteroaryl each of which is unsubstituted or substituted with one or more of halogen, hydroxy, amino, alkyl- or di(alkyl)amino, alkyl, cycloalkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, R 7 S(O)—, R 7 S(O) 2 —, R 7 C(O)—, R 7 R 8 NC(O)—, R 7 OC(O)—, R 7 C(O)O—, R 7 C(O)NR 8 —, —CN or —NO 2 ; or Y is Y-1, Y-2, Y-3, Y-4, Y-5, Y-6, Y-7, Y-8, Y-9, Y-10, Y-11, Y-12 or Y-13;

R 2 , R 3 are independently hydrogen, alkyl, haloalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl, alkoxylakyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, cycloalkyl, R 10 S(O)—, R 10 S(O) 2 —, R 10 C(O)—, R 10 C(S)—, R 10 R 11 NC(O)—, R 10 R 11 NC(S)—R 10 OC(O)—;

R 4 , R 5 and R 6 are independently hydrogen, alkyl, haloalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl, alkoxylakyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, cycloalkyl, aryl or heteroaryl;

R 7 and R 8 are independently hydrogen, alkyl, haloalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl, alkoxylakyl, alkenyl, haloalkenyl, alkynyl or haloalkynyl;

R 9 is hydrogen, halogen, —CN, or alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, cycloalkyl, halocycloalkyl, alkylcycloalkyl or cycloalkylalkyl, each which is unsubstituted or substituted with one or more of halogen, hydroxy, amino, alkyl- or di(alkyl)amino, alkyl, cycloalkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, R 7 S(O)—, R 7 S(O) 2 —, R 7 C(O)—, R 7 R 8 NC(O)—, R 7 OC(O)—, R 7 C(O)O—, R 7 C(O)NR 8 —, —CN or —NO 2 ;

R 10 , R 11 , R 12 and R 13 are each independently hydrogen, alkyl, haloalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl, alkoxylakyl, alkenyl, haloalkenyl, alkynyl or haloalkynyl; or

R 10 together with R 11 form ═O, ═S or ═NR 2 ; or

R 12 together with R 13 form ═O, ═S or ═NR 2 ;

W is O, S or NR 2 ;

n is 1-4; and

m is 0, 1 or 2.

2. The compound of claim 1 , wherein:

X is optionally substituted aryl.

3. The compound of claim 1 , wherein:

X is optionally substituted aryl;

R 1 is halogen, alkyl or haloalkyl; and

Y is Y-1, Y-2, Y-3, Y-4, Y-5, Y-6, Y-7, Y-8, Y-9, Y-10, Y-11, Y-12 or Y-13.

4. The compound of claim 1 , wherein:

X is optionally substituted aryl;

R 1 is halogen, alkyl or haloalkyl; and

Y is pyrazolyl or triazolyl.

5. The compound of claim 1 , wherein:

B 1 , B 2 , B 3 , B 4 and B 5 are each C—R 9 ;

R 1 is C 1 -C 4 alkyl or C 1 -C 4 haloalkyl;

X is phenyl, which may be unsubstituted or substituted by one or more halogen, C 1 -C 4 alkyl or C 1 -C 4 haloalkyl;

A 2 is CR 7 R 8 ;

Y is Y-1, Y-4, Y-5, Y-6;

R 3 and R 4 are independently hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 akoxy-C 1 -C 4 alkyl or C 1 -C 4 alkylthio-C 1 -C 4 alkyl; and

R 2 and R 9 are independently hydrogen, C 1 -C 4 alkyl or C 1 -C 4 haloalkyl.

6. The compound of claim 1 , wherein:

B 1 , B 2 , B 4 and B 5 are each C—R 9 ;

B 3 is N;

R 1 is C 1 -C 4 alkyl or C 1 -C 4 haloalkyl;

X is phenyl, which may be unsubstituted or substituted by one or more halogen, C 1 -C 4 alkyl or C 1 -C 4 haloalkyl;

A 1 is oxygen;

A 2 is CR 7 R 8 ;

Y is Y-1, Y-4, Y-5, Y-6;

R 3 and R 4 are independently hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 akoxy-C 1 -C 4 alkyl or C 1 -C 4 alkylthio-C 1 -C 4 alkyl; and

R 2 and R 9 are independently hydrogen, C 1 -C 4 alkyl or C 1 -C 4 haloalkyl.

7. The compound of claim 5 , wherein:

A 2 is CH 2 ,

R 9 is hydrogen;

R 10 together with R 11 form ═O, ═S or ═NR 2 ;

R 3 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 alkylthio-C 1 -C 4 -alkyl;

R 2 , R 7 and R 8 are each hydrogen; and

Y is Y-1 or Y-4.

8. The compound of claim 5 , wherein:

A 2 is CH 2 , R 9 is hydrogen;

R 10 together with R 11 form ═O, ═S or ═NR 2 ;

R 12 together with R 13 form ═O, ═S or ═NR 2 ;

R 3 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 alkylthio-C 1 -C 4 -alkyl;

R 2 , R 7 and R 8 are each hydrogen; and

Y is Y-1 or Y-4.

9. The compound of claim 5 , wherein:

A 2 is CH 2 ;

R 9 is hydrogen;

R 10 together with R 11 form ═O;

R 12 together with R 13 form ═O;

R 3 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 alkylthio-C 1 -C 4 -alkyl;

R 2 , R 7 and R 8 are hydrogen; and

Y is Y-1 or Y-4.

10. The compound of claim 6 , wherein:

A 2 is CH 2 ;

R 9 is hydrogen;

R 10 together with R 11 form ═O, ═S or ═NR 2 ;

R 3 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 alkylthio-C 1 -C 4 -alkyl;

R 2 , R 7 and R 8 are each hydrogen; and

Y is Y-1 or Y-4.

11. The compound of claim 6 , wherein:

A 2 is CH 2 ;

R 9 is hydrogen;

R 10 together with R 11 form ═O, ═S or ═NR 2 ;

R 12 together with R 13 form ═O, ═S or ═NR 2 ;

R 3 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 alkylthio-C 1 -C 4 -alkyl;

R 2 , R 7 and R 8 are each hydrogen; and

Y is Y-1 or Y-4.

12. The compound of claim 6 , wherein:

A 2 is CH 2 ;

R 9 is hydrogen;

R 10 together with R 11 form ═O;

R 12 together with R 13 form ═O;

R 3 is hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 alkylthio-C 1 -C 4 -alkyl;

R 2 , R 7 and R 8 are hydrogen; and

Y is Y-1 or Y-4.

13. A parasiticidal veterinary composition comprising an effective amount of a compound of formula (I) of claim 1 in combination with a pharmaceutically acceptable carrier.

14. A pesticidal composition comprising a pesticidally effective amount of a compound of formula (I) of claim 1 in combination with an agriculturally acceptable carrier or diluent.

15. The composition of claim 13 , wherein the composition comprises an additional active agent.

16. The composition of claim 15 , wherein the additional active agent is an arylpyrazole compound, an amino acetonitrile active agent, another isoxazoline active agent, a paraherquamide active agent, a benzimidazole, an imidazothiazole, a tetrahydropyrimidine active agent, an antitrematodal active agent, a macrocyclic lactone, an insect growth regulator, a neonicotinoid active agent, a pyrethroid, a formamidine or a spinosyn active agent.

17. The composition of claim 16 , wherein the macrocyclic lactone is abamectin, dimadectin, doramectin, emamectin, eprinomectin, ivermectin, latidectin, lepimectin, selamectin, milbemectin, milbemycin D, moxidectin, nemadectin or milbemycin oxime.

18. The compound of claim 9 , wherein:

Y is Y-1; and

R 3 is —CH 2 CH 2 SCH 3 .

19. The compound of claim 10 , wherein:

Y is Y-4; and

R 3 is —CH 2 CF 3 .

20. A dihydroazole compound of the formula:

or a pharmaceutically acceptable or agriculturally acceptable salt thereof, wherein Z, B 1 , B 2 , B 3 , B 4 , B 5 , R 15 , R 16 and p are selected from:

Compound

No.

(Z) p

B 5

B 4

B 3

B 2

B 1

R 15

R 16

2.001

3,5-Cl 2

C—H

C—H

N

C—H

C—H

H

CH 2 C(O)NHCH 2 CF 3

2.002

3,5-Cl 2

C—H

C—H

N

C—H

C—H

H

CH 2 CF 3

2.003

3,5-Cl 2

C—H

C—H

N

C—H

C—H

H

CH 2 CH 2 SCH 3

2.004

3,5-(CF 3 ) 2

C—H

C—H

N

C—H

C—H

H

CH 2 C(O)NHCH 2 CF 3

2.005

3,5-(CF 3 ) 2

C—H

C—H

N

C—H

C—H

H

CH 2 CF 3

2.006

3,5-(CF 3 ) 2

C—H

C—H

N

C—H

C—H

H

CH 2 CH 2 SCH 3

2.007

3-Cl,5-CF 3

C—H

C—H

N

C—H

C—H

H

CH 2 C(O)NHCH 2 CF 3

2.008

3-Cl,5-CF 3

C—H

C—H

N

C—H

C—H

H

CH 2 CF 3

2.009

3-Cl,5-CF 3

C—H

C—H

N

C—H

C—H

H

CH 2 CH 2 SCH 3

2.010

3,5-Cl 2

C—H

C—H

C—H

C—H

C—H

H

CH 2 C(O)NHCH 2 CF 3

2.011

3,5-Cl 2

C—H

C—H

C—H

C—H

C—H

H

CH 2 CF 3

2.012

3,5-Cl 2

C—H

C—H

C—H

C—H

C—H

H

CH 2 CH 2 SCH 3

2.013

3,5-(CF 3 ) 2

C—H

C—H

C—H

C—H

C—H

H

CH 2 C(O)NHCH 2 CF 3

2.014

3,5-(CF 3 ) 2

C—H

C—H

C—H

C—H

C—H

H

CH 2 CF 3

2.015

3,5-(CF 3 ) 2

C—H

C—H

C—H

C—H

C—H

H

CH 2 CH 2 SCH 3

2.016

3-Cl,5-CF 3

C—H

C—H

C—H

C—H

C—H

H

CH 2 C(O)NHCH 2 CF 3

2.017

3-Cl,5-CF 3

C—H

C—H

C—H

C—H

C—H

H

CH 2 CF 3

2.018

3-Cl,5-CF 3

C—H

C—H

C—H

C—H

C—H

H

CH 2 CH 2 SCH 3 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2015
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 034931/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2014
From: DE FALLOIS, LOIC PATRICK LE HIR; LEE, HYOUNG IK; WILKINSON, DOUGLAS EDWARD; BECK, BRENT CHRISTOPHER
To: MERIAL LIMITED
Reel/Frame 033324/0098 →
Continuity (3)
Division 12970670 · Dec 16, 2010
Provisional Application 61287532 · Dec 17, 2009
Related Publication 20140315794A1 · Oct 23, 2014